CV Technologies, founded in 1992, strives to transform people’s lives through the firm’s lead product COLD-FX which strengthens the immune system and is widely used as a leading over the counter remedy (“OTC”) for helping to prevent and relieve cold and flu infections.
Based on a strategic initiative the CV management realized the name “CV Technologies” did not convey the organizations rigorous life sciences orientation, and retained SL for a new name, identity and package design.